Exchange: NASDAQ·Updated 07:30 PM EDT
EXEL logo

EXEL Exelixis Inc

$56.71
$0.12
(0.21%)
Today
Closed $56.78
$0.07
(0.12%)
After Hours
EarningsOct 27
Mkt Cap$14.1B
Vol1.88M

About EXEL

Exelixis, Inc. is an oncology company, which focuses on discovering, developing, and commercialization of new medicines for difficult-to-treat cancers. Its products include cabometyx, cometriq, and cotellic. The company was founded by Stelios Papadopoulos on November 15, 1994, and is headquartered in Alameda, CA.
27

Bearish Sentiment

How do you feel about EXEL?

Advertisement|Remove ads.